# A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury

> **NCT05114226** · PHASE1 · UNKNOWN · sponsor: **West China Second University Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Radiation-Induced Dermatitis

## Interventions

- **DRUG:** Tetrahydrobiopterin

## Key facts

- **NCT ID:** NCT05114226
- **Lead sponsor:** West China Second University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05114226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05114226, "A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05114226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*